Thouraya Kammoun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thouraya Kammoun has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Imen Chabchoub
Pediatric Department, Hédi Chaker Hospital, Sfax, Tunisia
3 shared publications - Aloulou Hajer
Pediatrics Department - Hédi Chaker Sfax Hospital, Tunisia
2 shared publications - Fakhri Kallabi
Laboratory of Human Molecular Genetics - LR99ES33 - Faculty of Medicine of Sfax - University of Sfax, Tunisia
2 shared publications - Faten Hadj Kacem
Service d’endocrinologie, CHU Hédi Chaker, Sfax, Tunisie
2 shared publications - Ines Maaloul
Department of Pediatrics, Hedi Chaker Hospital, Sfax, Tunisia
2 shared publications - Leila Ammar-Keskes
Laboratory of Human Molecular Genetics, Faculty of Medicine of Sfax, Sfax, Tunisia
2 shared publications
Latest Publications
- 23 October 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
Schwachman Diamond-Like Syndrome Due to a Novel Variant of DNAJC21 Gene: A Case Report and Literature Review
Background: Shwachman-Diamond syndrome (SDS) is a rare inherited disorder characterized by hematological abnormalities, including varying degrees of cytopenia up to pancytopenia, in association with exocrine pancreatic insufficiency and skeletal defects. Observation: We report the case of a 13-month-old infant admitted for pancytopenia. Clinical examination revealed severe growth retardation, facial dysmorphism, and genu valgum. Bone marrow aspiration showed a hypoplastic marrow. He also had exocrine pancreatic insufficiency. Molecular analysis identified a homozygous pathogenic variant in the DNAJC21 gene. Conclusion: In this report, we detail the clinical spectrum, biological data, and genotype of a Tunisian child with a severe SDS-like phenotype caused by a novel pathogenic variant in the DNAJC21 gene.
- 23 October 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
Schwachman Diamond-Like Syndrome Due to a Novel Variant of DNAJC21 Gene: A Case Report and Literature Review
Background: Shwachman-Diamond syndrome (SDS) is a rare inherited disorder characterized by hematological abnormalities, including varying degrees of cytopenia up to pancytopenia, in association with exocrine pancreatic insufficiency and skeletal defects. Observation: We report the case of a 13-month-old infant admitted for pancytopenia. Clinical examination revealed severe growth retardation, facial dysmorphism, and genu valgum. Bone marrow aspiration showed a hypoplastic marrow. He also had exocrine pancreatic insufficiency. Molecular analysis identified a homozygous pathogenic variant in the DNAJC21 gene. Conclusion: In this report, we detail the clinical spectrum, biological data, and genotype of a Tunisian child with a severe SDS-like phenotype caused by a novel pathogenic variant in the DNAJC21 gene.
- 8 October 2025
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 86 (5) , 102461
Rare causes of pediatric primary adrenal insufficiency: Data from a large nationwide Tunisian cohort
- 8 October 2025
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 86 (5) , 102461
Rare causes of pediatric primary adrenal insufficiency: Data from a large nationwide Tunisian cohort
- Open Access
- 6 March 2025
- Published by Microbiology Society in Microbial Genomics
- Vol. 11 (3) , 001362
Molecular epidemiology of a multidrug-resistant Shigella sonnei outbreak in Tunisia (2022–2023) using whole-genome sequencing
Purpose. The prevalence of multidrug-resistant (MDR) Shigella sonnei is increasing globally, raising concerns for public health. In 2022, an outbreak of MDR S. sonnei was observed in Tunisia. We aimed to evaluate the genetic profile of S. sonnei isolates during the outbreak, including their clonal relationship, antimicrobial determinants and connection to international strains. Methods. In this study, we sequenced the whole genome of 24 S. sonnei strains collected from South Tunisia between July 2022 and November 2023. Bioinformatic analysis was conducted to confirm species identification, assign sequence types, determine core genome sequence types, analyse phylogenetic relationships and identify antimicrobial resistance determinants. Phylodynamic and phylogeographic analyses were performed to trace the spatiotemporal spread of the outbreak genotype. Results. Our investigation revealed that 23 out of 24 isolates were grouped into the HC10-20662 genotype within the 3.6.3 subclade. All isolates carried the blaCTX-M-15 gene associated with extended-spectrum beta-lactamase production, as well as the dfrA1 and qnrS1 genes, along with the D87G mutation in gyrA. Additionally, the sul2, tet(A) and mph(A) resistance genes were present in most isolates (96%, 96 and 83, respectively). Phylogeographic analysis suggested that the outbreak genotype likely spread in Europe before being introduced into Tunisia. Conclusion. To the best of our knowledge, this is the first MDR S. sonnei outbreak in the country. The HC10-20662 genotype appears to be responsible for a multi-country outbreak, affecting both Tunisia and Europe. Continued genomic surveillance efforts, both nationally and internationally, are essential for monitoring the dynamic evolution and global spread of MDR S. sonnei.
- 6 March 2025
- Published by Microbiology Society in Microbial Genomics
- Vol. 11 (3) , 001362
Open AccessMolecular epidemiology of a multidrug-resistant Shigella sonnei outbreak in Tunisia (2022–2023) using whole-genome sequencing
Purpose. The prevalence of multidrug-resistant (MDR) Shigella sonnei is increasing globally, raising concerns for public health. In 2022, an outbreak of MDR S. sonnei was observed in Tunisia. We aimed to evaluate the genetic profile of S. sonnei isolates during the outbreak, including their clonal relationship, antimicrobial determinants and connection to international strains. Methods. In this study, we sequenced the whole genome of 24 S. sonnei strains collected from South Tunisia between July 2022 and November 2023. Bioinformatic analysis was conducted to confirm species identification, assign sequence types, determine core genome sequence types, analyse phylogenetic relationships and identify antimicrobial resistance determinants. Phylodynamic and phylogeographic analyses were performed to trace the spatiotemporal spread of the outbreak genotype. Results. Our investigation revealed that 23 out of 24 isolates were grouped into the HC10-20662 genotype within the 3.6.3 subclade. All isolates carried the blaCTX-M-15 gene associated with extended-spectrum beta-lactamase production, as well as the dfrA1 and qnrS1 genes, along with the D87G mutation in gyrA. Additionally, the sul2, tet(A) and mph(A) resistance genes were present in most isolates (96%, 96 and 83, respectively). Phylogeographic analysis suggested that the outbreak genotype likely spread in Europe before being introduced into Tunisia. Conclusion. To the best of our knowledge, this is the first MDR S. sonnei outbreak in the country. The HC10-20662 genotype appears to be responsible for a multi-country outbreak, affecting both Tunisia and Europe. Continued genomic surveillance efforts, both nationally and internationally, are essential for monitoring the dynamic evolution and global spread of MDR S. sonnei.
- 1 May 2023
- Published by Springer Nature in Pediatric Cardiology
- Vol. 44 (6) , 1277-1284
Access to Care and Therapy for Kawasaki Disease in the Arab Countries: A Kawasaki Disease Arab Initiative (Kawarabi) Multicenter Survey
Kawasaki Disease (KD) is still the most common acquired heart disease in children below the age of five years; it has been well described in the developed world; however, data from the Arab world are limited to case reports or single-center case series. In an effort of optimizing KD research in the Arab world, a group of physicians and researchers established the KD Arab Initiative (Kawarabi) in 2021, and published the first survey, which showed disparities in the availability of intravenous immunoglobulin (IVIG); this had prompted Kawarabi to assess the access to care and therapy of KD patients in Arab countries. A 32 structured questions survey was conducted in thirteen Arab countries and addressed KD patients’ access to healthcare in urban and rural settings. The survey results showed that access to care was uniform across large, mid-size cities and rural areas in 7/13 (54%) countries, while in 6/13 (46%) countries, it was in favor of large and mid-size cities over rural areas. The quality of medical services received by children with KD in large cities was rated as excellent in 6/13 or good in 7/13 countries compared to fair in 4/13 or poor in 4/13 countries in rural areas. Availability of IVIG was limited (23%) in mid-size cities and almost impossible (23%) in rural areas. The KD patients in mid-size cities and rural areas have limited access to standard healthcare in the Arab world. This survey laid the foundation for future Kawarabi endeavors to improve the care of children with KD.
- 1 May 2023
- Published by Springer Nature in Pediatric Cardiology
- Vol. 44 (6) , 1277-1284
Access to Care and Therapy for Kawasaki Disease in the Arab Countries: A Kawasaki Disease Arab Initiative (Kawarabi) Multicenter Survey
Kawasaki Disease (KD) is still the most common acquired heart disease in children below the age of five years; it has been well described in the developed world; however, data from the Arab world are limited to case reports or single-center case series. In an effort of optimizing KD research in the Arab world, a group of physicians and researchers established the KD Arab Initiative (Kawarabi) in 2021, and published the first survey, which showed disparities in the availability of intravenous immunoglobulin (IVIG); this had prompted Kawarabi to assess the access to care and therapy of KD patients in Arab countries. A 32 structured questions survey was conducted in thirteen Arab countries and addressed KD patients’ access to healthcare in urban and rural settings. The survey results showed that access to care was uniform across large, mid-size cities and rural areas in 7/13 (54%) countries, while in 6/13 (46%) countries, it was in favor of large and mid-size cities over rural areas. The quality of medical services received by children with KD in large cities was rated as excellent in 6/13 or good in 7/13 countries compared to fair in 4/13 or poor in 4/13 countries in rural areas. Availability of IVIG was limited (23%) in mid-size cities and almost impossible (23%) in rural areas. The KD patients in mid-size cities and rural areas have limited access to standard healthcare in the Arab world. This survey laid the foundation for future Kawarabi endeavors to improve the care of children with KD.
- Open Access
- 20 December 2022
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 227, 106235
Molecular mechanisms underlying the defects of two novel mutations in the HSD17B3 gene found in the Tunisian population
- 20 December 2022
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 227, 106235
Open AccessMolecular mechanisms underlying the defects of two novel mutations in the HSD17B3 gene found in the Tunisian population
- 13 July 2022
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 41 (8) , e324-e325
Guillain-Barré Syndrome in a Child With Multisystem Inflammatory Syndrome Related to COVID-19
Guillain-Barré syndrome has been associated with acute severe acute respiratory syndrome coronavirus 2 infection in children. Here, we report a 4-year-old boy who developed Guillain-Barré syndrome in the course of multisystem inflammatory syndrome related to COVID-19.
- 13 July 2022
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 41 (8) , e324-e325
Guillain-Barré Syndrome in a Child With Multisystem Inflammatory Syndrome Related to COVID-19
Guillain-Barré syndrome has been associated with acute severe acute respiratory syndrome coronavirus 2 infection in children. Here, we report a 4-year-old boy who developed Guillain-Barré syndrome in the course of multisystem inflammatory syndrome related to COVID-19.